Pavmed INC. (PAVM) — SC 13D/A Filings

All SC 13D/A filings from Pavmed INC.. Browse 3 SC 13D/A reports with AI-powered summaries and risk analysis.

SC 13D/A Filings (3)

PAVmed Inc. Amends Lucid Diagnostics Stake Filing — Dec 12, 2024 Risk: medium
PAVmed Inc. filed an amendment (No. 4) to its Schedule 13D on December 12, 2024, concerning its beneficial ownership of Lucid Diagnostics Inc. common stock. The
PAVmed Amends Lucid Diagnostics Stake — Feb 20, 2024 Risk: low
PAVmed Inc. filed an SC 13D/A Amendment No. 3 on February 20, 2024, regarding its ownership in Lucid Diagnostics Inc. The filing indicates PAVmed Inc. holds Com
PAVmed Amends Lucid Diagnostics Stake, Signals Ownership Update — Feb 2, 2024
PAVmed Inc. filed an amended Schedule 13D/A on February 2, 2024, updating its beneficial ownership of Lucid Diagnostics Inc. common stock. This amendment, speci

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX